Bright Minds Biosciences Inc. (DRUG)
NASDAQ·Healthcare·Biotechnology
$64.06
-1.45%
Mkt Cap $636.16M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (7 analysts)
$163.67
Range $126.00 – $220.00
Implied Upside
+155.5%
Consensus $163.67 vs current $64.06